These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11920183)

  • 1. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis.
    Tchernia G; Delhommeau F; Perrotta S; Cynober T; Bader-Meunier B; Nobili B; Rohrlich P; Salomon JL; Sagot-Bevenot S; del Giudice EM; Delaunay J; DeMattia D; Schischmanoff PO; Mohandas N; Iolascon A;
    Hematol J; 2000; 1(3):146-52. PubMed ID: 11920183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant Human Erythropoietin (r-HuEPO) therapy in a newborn with hereditary spherocytosis].
    Schiff M; Haÿs S; Sann L; Putet G
    Arch Pediatr; 2003 Apr; 10(4):333-6. PubMed ID: 12818755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant erythropoietins--an alternative therapy to red cell blood transfusions in infants with hereditary spherocytosis].
    Neuman-Łaniec M; Wierzba J; Irga N; Wasilewska E; Balcerska A
    Przegl Lek; 2002; 59(10):871-2. PubMed ID: 12632932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of hereditary spherocytosis during the first year of life.
    Delhommeau F; Cynober T; Schischmanoff PO; Rohrlich P; Delaunay J; Mohandas N; Tchernia G
    Blood; 2000 Jan; 95(2):393-7. PubMed ID: 10627440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.
    Ohls RK; Harcum J; Schibler KR; Christensen RD
    J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants.
    Khatami SF; Mamouri G; Torkaman M
    Indian J Pediatr; 2008 Dec; 75(12):1227-30. PubMed ID: 19057854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.
    Morrison JF; Neufeld EJ; Grace RF
    Eur J Haematol; 2014 Aug; 93(2):161-4. PubMed ID: 24660843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of erythropoietin to prevent red blood cell transfusion in a 2018-2020 two-center cohort of preterm infants.
    Bailly N; Brat R; Favrais G
    Blood Transfus; 2024 Jul; 22(4):303-311. PubMed ID: 38315537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants.
    Carnielli VP; Da Riol R; Montini G
    Arch Dis Child Fetal Neonatal Ed; 1998 Jul; 79(1):F44-8. PubMed ID: 9797624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful recombinant erythropoietin therapy for a developing anemic newborn with hereditary spherocytosis.
    Hosono S; Hosono A; Mugishima H; Nakano Y; Minato M; Okada T; Takahashi S; Harada K
    Pediatr Int; 2006 Apr; 48(2):178-80. PubMed ID: 16635181
    [No Abstract]   [Full Text] [Related]  

  • 11. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
    Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
    Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Farruggia P; Puccio G; Ramenghi U; Colombatti R; Corti P; Trizzino A; Barone A; Boscarol G; Ferraro F; Grotto P; Lo Valvo L; Luti L; Matarese SMR; Mosa C; Putti MC; Rubert L; Ruffo GB; Sainati L; Tartaglione I; Russo G; Perrotta S
    Am J Hematol; 2017 Jun; 92(6):E103-E105. PubMed ID: 28263406
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates.
    Soubasi V; Kremenopoulos G; Tsantali C; Savopoulou P; Mussafiris C; Dimitriou M
    Biol Neonate; 2000 Nov; 78(4):281-7. PubMed ID: 11093007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial.
    Ohls RK; Ehrenkranz RA; Wright LL; Lemons JA; Korones SB; Stoll BJ; Stark AR; Shankaran S; Donovan EF; Close NC; Das A
    Pediatrics; 2001 Oct; 108(4):934-42. PubMed ID: 11581447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.
    Saleh MI; Nalbant D; Widness JA; Veng-Pedersen P
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R772-81. PubMed ID: 23485870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.